Completed PHASE1 INTERVENTIONAL 2-arm NCT02631642

A Study of HMPL-689 in Healthy Volunteers

A Phase I,Randomized,Double Blinded,Placebo-controlled,Dose-escalating Study of the Safety,Tolerability and Pharmacokinetics of HMPL-689 in Healthy Volunteers

Sponsor: Hutchison Medipharma Limited

Conditions Healthy Volunteers

Interventions HMPL-689 HMPL-689 placebo

Updated 9 times since 2017 Last updated: Aug 15, 2017 Started: Mar 23, 2016 Primary completion: Oct 26, 2016 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Volunteers and is currently completed. Hutchison Medipharma Limited leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Nov 2022 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Nov 2022 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 4 earlier versions

Sep 2017 — Jun 2018 [monthly]

Completed PHASE1
Apr 2017 — Sep 2017 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Feb 2017 — Apr 2017 [monthly]

Active Not Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hutchison Medipharma Limited

Data source: Hutchmed

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia